Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-21

Clinical Trial Update: A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effectiveness of Jitongning Tablets versus placebo in adults with Ankylosing Spondylitis; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Jitongning Tablets

Snippet

Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: Ankylosing Spondylitis | Phase 3 | Status: RECRUITING